Works matching AU Callahan, Margaret K.

Results: 24

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.

Published in:

Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf017

By:

Nykaza, Ian;
Murciano-Goroff, Yonina R;
Desilets, Antoine;
Harada, Guilherme;
Postow, Michael A;
Callahan, Margaret K;
Lee, Chung-Han;
Rudin, Charles M;
Kelsen, David Paul;
Stadler, Zsofia K;
Wibmer, Andreas G;
Hechtman, Jaclyn F;
Drilon, Alexander;
Friedman, Claire F

Publication type:

Article

Improving the Therapeutic Benefits of Ipilimumab.

Published in:

Oncology (08909091), 2010, v. 24, n. 14, p. 1288

By:

SUBUDHI, SUMIT K.;
CALLAHAN, MARGARET K.;
WOLCHOK, JEDD D.

Publication type:

Article

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.

Published in:

JNCI Cancer Spectrum, 2018, v. 2, n. 3, p. 1, doi. 10.1093/jncics/pky021

By:

Girotra, Monica;
Hansen, Aaron;
Farooki, Azeez;
Byun, David J;
Min, Le;
Creelan, Ben C;
Callahan, Margaret K;
Atkins, Michael B;
Sharon, Elad;
Antonia, Scott J;
West, Pamela;
Gravell, Amy E;
collaboration, Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force

Publication type:

Article

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Published in:

Nature Medicine, 2012, v. 18, n. 6, p. 883, doi. 10.1038/nm.2753

By:

Peinado, Héctor;
Ale?kovi?, Maša;
Lavotshkin, Simon;
Matei, Irina;
Costa-Silva, Bruno;
Moreno-Bueno, Gema;
Hergueta-Redondo, Marta;
Williams, Caitlin;
García-Santos, Guillermo;
Ghajar, Cyrus M;
Nitadori-Hoshino, Ayuko;
Hoffman, Caitlin;
Badal, Karen;
Garcia, Benjamin A;
Callahan, Margaret K;
Yuan, Jianda;
Martins, Vilma R;
Skog, Johan;
Kaplan, Rosandra N;
Brady, Mary S

Publication type:

Article

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Published in:

2013

By:

Luke, Jason J;
Callahan, Margaret K;
Postow, Michael A;
Romano, Emanuela;
Ramaiya, Nikhil;
Bluth, Mark;
Giobbie-Hurder, Anita;
Lawrence, Donald P;
Ibrahim, Nageatte;
Ott, Patrick A;
Flaherty, Keith T;
Sullivan, Ryan J;
Harding, James J;
D'Angelo, Sandra;
Dickson, Mark;
Schwartz, Gary K;
Chapman, Paul B;
Wolchok, Jedd D;
Hodi, F Stephen;
Carvajal, Richard D

Publication type:

journal article

Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282

By:

Luke, Jason J.;
Callahan, Margaret K.;
Postow, Michael A.;
Romano, Emanuela;
Ramaiya, Nikhil;
Bluth, Mark;
Giobbie‐Hurder, Anita;
Lawrence, Donald P.;
Ibrahim, Nageatte;
Ott, Patrick A.;
Flaherty, Keith T.;
Sullivan, Ryan J.;
Harding, James J.;
D'Angelo, Sandra;
Dickson, Mark;
Schwartz, Gary K.;
Chapman, Paul B.;
Wolchok, Jedd D.;
Hodi, F. Stephen;
Carvajal, Richard D.

Publication type:

Article

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.

Published in:

2017

By:

Friedman, Claire F.;
Clark, Varina;
Raikhel, Andrew V.;
Barz, Tim;
Shoushtari, Alexander N.;
Momtaz, Parisa;
Callahan, Margaret K.;
Wolchok, Jedd D.;
Chapman, Paul B.;
Hellmann, Matthew D.;
Postow, Michael A.

Publication type:

journal article

The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming.

Published in:

Science Translational Medicine, 2025, v. 17, n. 793, p. 1, doi. 10.1126/scitranslmed.adk3702

By:

Rolig, Annah S.;
Peng, Xiyu;
Sturgill, Elizabeth R.;
Holay, Nisha;
Kasiewicz, Melissa;
Mick, Courtney;
Mcgee, Grace Helen;
Miller, William;
Koguchi, Yoshinobu;
Kaufmann, Johanna;
Yanamandra, Niranjan;
Griffin, Sue;
Smothers, James;
Adamow, Matthew;
Lee, Jasme;
Shen, Ronglai;
Callahan, Margaret K.;
Redmond, William L.

Publication type:

Article

Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 4, p. 1180, doi. 10.1245/s10434-019-08099-9

By:

Bello, Danielle M.;
Panageas, Katherine S.;
Hollmann, Travis;
Shoushtari, Alexander N.;
Momtaz, Parisa;
Chapman, Paul B.;
Postow, Michael A.;
Callahan, Margaret K.;
Wolchok, Jedd D.;
Brady, Mary S.;
Coit, Daniel G.;
Ariyan, Charlotte E.

Publication type:

Article

Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials.

Published in:

Cancer (0008543X), 2020, v. 126, n. 22, p. 4967, doi. 10.1002/cncr.33153

By:

Mondaca, Sebastian P.;
Liu, Dazhi;
Flynn, Jessica R.;
Badson, Sandy;
Hamaway, Stefan;
Gounder, Mrinal M.;
Khalil, Danny N.;
Drilon, Alexander E.;
Li, Bob T.;
Jhaveri, Komal L.;
Schram, Alison M.;
Kargus, Katherine E.;
Kasler, Mary Kate;
Blauvelt, Natalie M.;
Segal, Neil H.;
Capanu, Marinela;
Callahan, Margaret K.;
Hyman, David M.;
Gambarin‐Gelwan, Maya;
Harding, James J.

Publication type:

Article

Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.

Published in:

Oncologist, 2023, v. 28, n. 4, p. 351, doi. 10.1093/oncolo/oyac266

By:

Atkinson, Thomas M;
Hay, Jennifer L;
Kim, Soo Young;
Schofield, Elizabeth;
Postow, Michael A;
Momtaz, Parisa;
Warner, Allison Betof;
Shoushtari, Alexander N;
Callahan, Margaret K;
Wolchok, Jedd D;
Li, Yuelin;
Chapman, Paul B

Publication type:

Article

Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience.

Published in:

Oncologist, 2019, v. 24, n. 5, p. e196, doi. 10.1634/theoncologist.2019-0040

By:

Lee Chuy, Katherine;
Oikonomou, Evangelos K.;
Postow, Michael A.;
Callahan, Margaret K.;
Chapman, Paul B.;
Shoushtari, Alexander N.;
Neilan, Tomas G.;
Fradley, Michael G.;
Ramanathan, Lakshmi V.;
Wolchok, Jedd D.;
Steingart, Richard M.;
Gupta, Dipti

Publication type:

Article

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.

Published in:

Oncologist, 2016, v. 21, n. 7, p. 848, doi. 10.1634/theoncologist.2015-0522

By:

Kuk, Deborah;
Shoushtari, Alexander N.;
Barker, Christopher A.;
Panageas, Katherine S.;
Munhoz, Rodrigo R.;
Momtaz, Parisa;
Ariyan, Charlotte E.;
Brady, Mary Sue;
Coit, Daniel G.;
Bogatch, Kita;
Callahan, Margaret K.;
Wolchok, Jedd D.;
Carvajal, Richard D.;
Postow, Michael A.

Publication type:

Article

Ipilimumab for Patients With Advanced Mucosal Melanoma.

Published in:

Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464

By:

Postow, Michael A.;
Luke, Jason J.;
Bluth, Mark J.;
Ramaiya, Nikhil;
Panageas, Katherine S.;
Lawrence, Donald P.;
Ibrahim, Nageatte;
Flaherty, Keith T.;
Sullivan, Ryan J.;
Ott, Patrick A.;
Callahan, Margaret K.;
Harding, James J.;
D'Angelo, Sandra P.;
Dickson, Mark A.;
Schwartz, Gary K.;
Chapman, Paul B.;
Gnjatic, Sacha;
Wolchok, Jedd D.;
Hodi, F. Stephen;
Carvajal, Richard D.

Publication type:

Article

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

Published in:

Cancer Medicine, 2018, v. 7, n. 3, p. 690, doi. 10.1002/cam4.1356

By:

Rosner, Samuel;
Kwong, Erica;
Shoushtari, Alexander N.;
Friedman, Claire F.;
Betof, Allison S.;
Brady, Mary Sue;
Coit, Daniel G.;
Callahan, Margaret K.;
Wolchok, Jedd D.;
Chapman, Paul B.;
Panageas, Katherine S.;
Postow, Michael A.

Publication type:

Article

CTLA-4 and PD-1 pathway blockade: combinations in the clinic.

Published in:

Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2014.00385

By:

Callahan, Margaret K.;
Postow, Michael A.;
Wolchok, Jedd D.

Publication type:

Article

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.

Published in:

Nature Communications, 2016, v. 7, n. 2, p. 10391, doi. 10.1038/ncomms10391

By:

Dubin, Krista;
Callahan, Margaret K.;
Ren, Boyu;
Khanin, Raya;
Viale, Agnes;
Ling, Lilan;
No, Daniel;
Gobourne, Asia;
Littmann, Eric;
Huttenhower, Curtis;
Pamer, Eric G.;
Wolchok, Jedd D.

Publication type:

Article

On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation.

Published in:

Science Translational Medicine, 2015, v. 7, n. 280, p. 1, doi. 10.1126/scitranslmed.3010274

By:

Lesokhin, Alexander M.;
Callahan, Margaret K.;
Postow, Michael A.;
Wolchok, Jedd D.

Publication type:

Article

Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody.

Published in:

Science Translational Medicine, 2014, v. 6, n. 230, p. 1, doi. 10.1126/scitranslmed.3008002

By:

Iwama, Shintaro;
De Remigis, Alessandra;
Callahan, Margaret K.;
Slovin, Susan F.;
Wolchok, Jedd D.;
Caturegli, Patrizio

Publication type:

Article

Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab.

Published in:

Pigment Cell & Melanoma Research, 2024, v. 37, n. 6, p. 801, doi. 10.1111/pcmr.13179

By:

Lochrin, Sarah E.;
Buonocore, Darren J.;
Young, Robert J.;
Kaley, Thomas J.;
Postow, Michael A.;
Wolchok, Jedd D.;
Shoushtari, Alexander N.;
Momtaz, Parisa;
Betof Warner, Allison S.;
Callahan, Margaret K.

Publication type:

Article

Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1.

Published in:

Pigment Cell & Melanoma Research, 2023, v. 36, n. 3/4, p. 314, doi. 10.1111/pcmr.13083

By:

Loo, Kimberly;
Kalvin, Hannah L.;
Panageas, Katherine S.;
Callahan, Margaret K.;
Chapman, Paul B.;
Momtaz, Parisa;
Shoushtari, Alexander N.;
Wolchok, Jedd D.;
Postow, Michael A.;
Warner, Allison Betof

Publication type:

Article

Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab.

Published in:

Pigment Cell & Melanoma Research, 2015, v. 28, n. 5, p. 611, doi. 10.1111/pcmr.12383

By:

Minor, David R.;
Puzanov, Igor;
Callahan, Margaret K.;
Hug, Bruce A.;
Hoos, Axel

Publication type:

Article

Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma.

Published in:

Journal of Pathology, 2023, v. 261, n. 3, p. 349, doi. 10.1002/path.6197

By:

Vanguri, Rami S;
Smithy, James W;
Li, Yanyun;
Zhuang, Mingqiang;
Maher, Colleen A;
Aleynick, Nathaniel;
Peng, Xiyu;
Al‐Ahmadie, Hikmat;
Funt, Samuel A;
Rosenberg, Jonathan E;
Iyer, Gopa;
Bajorin, Dean;
Mathews, James C;
Nadeem, Saad;
Panageas, Katherine S;
Shen, Ronglai;
Callahan, Margaret K;
Hollmann, Travis J

Publication type:

Article

Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.

Published in:

Head & Neck, 2016, v. 38, n. 9, p. 1310, doi. 10.1002/hed.24435

By:

Samstein, Robert M.;
Carvajal, Richard D.;
Postow, Michael A.;
Callahan, Margaret K.;
Shoushtari, Alexander N.;
Patel, Snehal G.;
Lee, Nancy Y.;
Barker, Christopher A.

Publication type:

Article